
|
03월 13일 금요일
08:30-08:40 |
Opening Ceremony
|
1층 엑스포홀 | |
|---|---|---|---|
|
03월 13일 금요일
08:40-10:10 |
기초 세션 I
Foundations and Evolving Concepts in Transplantation Immunology |
1층 엑스포홀 | |
|---|---|---|---|
| 좌장 |
홍승희 (연세대 생화학과) 권호근 (연세의대) |
||
| 08:40-09:00 |
Recent Advance of T Cell in Transplantation Immunology
하상준 (연세대 생화학과) |
||
| 09:00-09:20 |
Recent Advance in Antigen Presenting Cells in Transplantation Immunology
김유미 (한국과학기술원 (KAIST) 의과학과) |
||
| 09:20-09:40 |
Recent Advance of B Cell in Transplantation Immunology
오지은 (한국과학기술원 (KAIST) 의과학과) |
||
| 09:40-10:00 |
Peripheral and Central Tolerance in Transplantation
홍준영 (연세대 시스템생명과) |
||
| 10:00-10:10 |
Discussion
하상준 (연세대 생화학과), 김유미 (한국과학기술원 (KAIST) 의과학과), 오지은 (한국과학기술원 (KAIST) 의과학과), 홍준영 (연세대 시스템생명과) |
||
|
03월 13일 금요일
08:40-10:10 |
CTR 리뷰어 인증 교육 I
How to improve quality of CTR for AI era |
B1층 세미나실 4 | |
|---|---|---|---|
| 좌장 |
오은지 (가톨릭의대) 김성훈 (국립암센터) |
||
| 08:40-09:10 |
Recent advance and vision for CTR progress to SCI journal
김경식 (한양의대) |
||
| 09:10-09:40 |
Editorial Strategy, Impact Factor Management, and Future Directions of the Annals of Surgical Treatment and Research
김덕우 (분당서울대학교병원) |
||
| 09:40-10:10 |
Overview and Strategic Evolution of Experimental & Molecular Medicine (EMM)
국현 (전남의대 약리학교실) |
||
|
03월 13일 금요일
10:30-12:00 |
기초 세션 II
Technological Frontiers in Transplantation Immune Research |
1층 엑스포홀 | |
|---|---|---|---|
| 좌장 |
이기영 (성균관의대) 오지은 (한국과학기술원 (KAIST) 의과학과) |
||
| 10:30-10:50 |
Immunological Strategies for Immune Monitoring in Transplantation
정민경 (Institute for Basic Science (IBS)) |
||
| 10:50-11:10 |
Omics-Based Approaches for Transplantation Immune Monitoring
류희주 (성균관의대) |
||
| 11:10-11:30 |
Single-Cell Transcriptomics in Transplantation Immunology
박종은 (Institute for Basic Science (IBS)) |
||
| 11:30-11:50 |
Spatial Omics and Tissue-Resolved Immune Landscapes in Transplantation
홍승희 (연세대 생화학과) |
||
| 11:50-12:10 |
Discussion
정민경 (Institute for Basic Science (IBS)), 류희주 (성균관의대), 박종은 (Institute for Basic Science (IBS)), 홍승희 (연세대 생화학과) |
||
|
03월 13일 금요일
10:30-12:00 |
CTR 리뷰어 인증 교육 II
How to improve quality of CTR for AI era |
B1층 세미나실 4 | |
|---|---|---|---|
| 좌장 |
최동호 (한양의대) 한승엽 (계명의대) |
||
| 10:30-11:00 |
How to us KOTRY Data to Publish for CTR
김명수 (연세의대) |
||
| 11:00-11:30 |
AI Application in Manuscript Writing for CTR
권현욱 (울산의대) |
||
| 11:30-12:00 |
Big Data Management of Manuscript Writing for CTR
박보영 (한양의대) |
||
|
03월 13일 금요일
12:00-13:00 |
Luncheon Symposium I 아스텔라스
|
1층 컨퍼런스홀 | |
|---|---|---|---|
| 좌장 |
허규하 (연세의대) 한영석 (대구가톨릭의대) |
||
| 12:00-12:30 |
Balancing Rejection and Infection Risk with Tacrolimus in Kidney Transplantation: Clinical Insights from BKPyV-DNAemia
권현욱 (울산의대) |
||
| 12:30-13:00 |
Under-Immunosuppression Risk in Liver Transplantation: Clinical Implications for dnDSA Development and Graft Outcomes
김석환 (충남의대) |
||
|
03월 13일 금요일
12:00-13:00 |
Luncheon Symposium II 사노피
Risk-Driven Precision Induction in Kidney Transplantation |
B1층 세미나실 4 | |
|---|---|---|---|
| 좌장 | 박재범 (성균관의대) | ||
| 12:00-12:30 |
Risk Stratification in Kidney Transplantation & Induction Strategy Overview
이주한 (연세의대) |
||
| 12:30-13:00 |
Individualized ATG Induction Therapy: Optimizing Early Outcomes in Kidney Transplantation
방준배 (아주의대) |
||
|
03월 13일 금요일
13:00-14:30 |
정책 세션 I
Organ Shortage Solutions 2026: From Current Landscape to DCD Implementation |
1층 엑스포홀 | |
|---|---|---|---|
| 좌장 |
김명수 (연세의대) 김범석 (연세의대) |
||
| 13:00-13:15 |
Organ Shortage in Korea and Policy Levers: What Must Change and How
이삼열 (한국장기조직기증원 (KODA)) |
||
| 13:15-13:35 |
Expanding Living Donation: Managing Marginal Donors and Risk Profiles
신병철 (조선의대) |
||
| 13:35-13:50 |
Overcoming Immunological Barriers: Revisiting Paired Donation and Scaling Access
강은정 (서울대병원 장기이식센터) |
||
| 13:50-14:10 |
Implementing a Korea-Specific DCD Model: Key Issues, Governance, and Workflow
조혜성 (서울의대) |
||
| 14:10-14:30 |
Panel Discussion: A Korea Roadmap for Organ Supply Expansion—Priorities and Next Steps
안형준 (경희의대), 김희선 (보건복지부 혈액장기정책과) |
||
|
03월 13일 금요일
14:40-16:10 |
윤리세션
생체 장기 공여자의 안전과 자율성 보호 (safety and autonomy of Living donor organ donors) |
1층 엑스포홀 | |
|---|---|---|---|
| 좌장 |
황정기 (가톨릭의대) 오지은 (강동성심병원) |
||
| 14:40:14:55 |
신장이식 공여자의 의학적 안전과 장기추적관리
장혜련 (성균관의대) |
||
| 14:55-15:10 |
간이식 공여자의 의학적 안전과 장기추적관리
김나름 (연세의대) |
||
| 15:10-15:30 |
기증 후 삶의 질 향상을 위한 심리/사회적 건강관리
정사임 (고려의대 정신건강의학과) |
||
| 15:30-15:50 |
생체 기증 승인 과정에서의 윤리적 지향점: 가족 공동체의 유대와 개인의 자율성
이일학 (연세의대) |
||
| 15:50-16:10 |
Panel Discussion
손선영 (대한장기이식 코디네이터협회 (KOTCO)), 정대희 (서울대학교병원 사회사업팀), 전강웅 (가톨릭의대) |
||
|
03월 13일 금요일
16:20-17:30 |
교육세션
Together for Transplantation: KST & the Next Generation |
1층 컨퍼런스홀 | |
|---|---|---|---|
| 좌장 |
김범석 (연세의대) 박재범 (성균관의대) |
||
| 16:20-16:30 |
KST for Young
김범석 (연세의대) |
||
| 16:30-16:38 |
Together with KST: 한국장기조직기증원(KODA)
강현진 (한국장기조직기증원(KODA)) |
||
| 16:38-16:46 |
Together with KST: 생명잇기(Vitallink)
김영훈 (인제의대) |
||
| 16:46-16:54 |
Together with KST: KOTCO
손선영 (대한장기이식 코디네이터협회 (KOTCO)) |
||
| 16:54-17:02 |
Together with KST: KOTRY
양재석 (연세의대) |
||
| 17:02-17:10 |
Together with KST: ASTREG
정종철 (분당서울대학교병원) |
||
| 17:10-17:30 | KST Town Hall with the Next Generation | ||
|
03월 13일 금요일
17:30-18:10 |
젊은 이식의료인 reception
|
1층 컨퍼런스홀 | |
|---|---|---|---|
|
03월 14일 토요일
08:00-09:30 |
연구과제 보고
|
B1층 세미나실 4 | |
|---|---|---|---|
| 좌장 |
허규하 (연세의대) 민상일 (서울의대) |
||
| 08:00-08:30 |
장기이식에서 고해상도 조직적합성 형별 검사의 국내외 적용 현황 조사 및 진단표준화를 위한 임상 적응증 제안 연구
박금보래 (한국장기조직기증원(KODA)) |
||
| 08:30-09:00 |
뇌사 신장이식 대기자의 감작 정도가 뇌사이식 대기기간에 미치는 영향 분석
양재석 (연세의대) |
||
| 09:00-09:30 |
뇌사자 신장 배분에서 교차반응 실시 및 배제 기준 설정 방안
강은숙 (성균관의대) |
||
|
03월 14일 토요일
08:00-09:30 |
유관기관 보고
|
B1층 세미나실 1 | |
|---|---|---|---|
| 좌장 |
김명수 (연세의대) 김범석 (연세의대) |
||
| 08:00-08:30 |
2025년 생명잇기 기관보고
김영훈 (인제의대) |
||
| 08:30-09:00 |
한국장기조직기증원 (KODA)
이삼열 (한국장기조직기증원 (KODA)) |
||
| 09:00-09:30 |
KOTRY; 12년의 역사와 새로운 시작
김명수 (연세의대) |
||
|
03월 14일 토요일
08:00-09:30 |
Poster Presentation
|
2F 엑스포홀 로비 | |
|---|---|---|---|
|
03월 14일 토요일
09:40-10:40 |
Special Symposium
Clinical Xenotransplantation: From Compassionate Use to First-in-Human Trials |
1층 엑스포홀 | |
|---|---|---|---|
| 좌장 |
윤익진 (건국의대) 김범석 (연세의대) |
||
| 09:40-09:50 |
Clinical Xenotransplantation: Global Update and Key Lessons Learned
민상일 (서울의대) |
||
| 09:50-10:10 |
Source Pig Engineering & Manufacturing: Defining “Clinical-Grade” Standards
김현일 (옵티팜) |
||
| 10:10-10:25 |
Immunosuppression Strategies in Xenotransplantation: Current Knowledge and Future Directions
양재석 (연세의대) |
||
| 10:25-10:40 |
Ensuring Infection Safety and Establishing Long-Term Surveillance: Building Trust Through Rigorous Monitoring
오일웅 (식품의약품안전처) |
||
|
03월 14일 토요일
11:00-12:30 |
Concurrent Symposium I - (Kidney/Pancreas I)
Next-Generation Technologies in Transplantation |
1층 엑스포홀 | |
|---|---|---|---|
| 좌장 |
이종수 (울산의대) 민상일 (서울의대) |
||
| 11:00-11:20 |
Artificial intelligence in medical field
고동률 (솔트룩스) |
||
| 11:20-11:40 |
Integrating Digital Health into Clinical Medicine for Patient Monitoring and Management
조재형 (가톨릭의대 내분비내과) |
||
| 11:40-12:00 |
Implementing Telemedicine in Clinical Practice: Evidence from Real-World Studies
신재용 (연세의대 예방의학과) |
||
| 12:00-12:20 |
Stem Cell–Derived Islet Cells: Current Advances and Future Perspectives
임동현 (한양대 생명공학부) |
||
| 12:20-12:30 | Q&A | ||
|
03월 14일 토요일
11:00-12:30 |
Concurrent Symposium II - (Liver I)
Challenges and Dilemmas in LT for Acute-on-Chronic Liver Failure (ACLF) |
1층 컨퍼런스홀 | |
|---|---|---|---|
| 좌장 |
이해원 (서울의대) 박정익 (울산의대) |
||
| 11:00-11:20 |
What is ACLF?: Definition, Pathophysiology, and Medical Bridging for ACLF
장정원 (가톨릭의대) |
||
| 11:20-11:40 |
The Golden Window: Timing, Utility, and Futility of LT in ACLF
김태석 (계명의대) |
||
| 11:40-12:00 |
Can We Expect Success? Outcomes and Risk Stratification in LT for ACLF
최규성 (성균관의대) |
||
| 12:00-12:20 |
How to Manage the Crisis: Essential Perioperative Considerations for ACLF
윤영인 (울산의대) |
||
| 12:20-12:30 | Discussion | ||
|
03월 14일 토요일
11:00-12:30 |
Concurrent Symposium V - (Coordinator)
장기이식 코디네이터의 번아웃 관리와 전문성 증진 |
B1층 세미나실 4 | |
|---|---|---|---|
| 좌장 |
김인옥 (울산의대) 장혜연 (일산백병원) |
||
| 11:00-11:30 |
장기이식 코디네이터의 번아웃과 Motivation
유문원 (울산의대) |
||
| 11:30-12:00 |
판단을 구조로 옮기는 QI 접근
김현화 (인하의대) |
||
| 12:00-12:30 |
장기이식코디네이터와 병원 수익의 상관 관계
오선영 (부산대학교병원 장기이식센터) |
||
|
03월 14일 토요일
11:00-12:30 |
Concurrent Symposium III - Heart (중증심부전연구회와 joint symposium)
From Temporary MCS to Transplant: Practical Management Across the Continuum |
B1층 세미나실 1 | |
|---|---|---|---|
| 좌장 |
강석민 (연세의대) 최진오 (성균관의대) |
||
| 11:00-11:15 |
Making Drugs Work on ECMO/CentriMag: From PK/PD Pitfalls to Vasopressors, Anti-infectives, and GDMT
이주연 (연세의대) |
||
| 11:15-11:30 |
Hemostasis on ECMO/CentriMag: Anticoagulation, Bleeding/Thrombosis Trade-offs, and Inflammation
이유리 (서울의대) |
||
| 11:30-11:45 |
Choosing the Next Step: Transition Strategies From ECMO/CentriMag to Durable LVAD or Transplant
김아람 (울산의대) |
||
| 11:45-12:00 |
After the Bridge: Post-Transplant Management Differences After ECMO/CentriMag, Durable LVAD, or No-MCS Medical Bridging
홍정애 (울산의대) |
||
| 12:00-12:30 |
Discussion
이상언 (울산의대), 정인석 (전남의대), 윤종찬 (가톨릭의대), 황호영 (서울의대), 정성호 (울산의대), 조현재 (서울의대) |
||
|
03월 14일 토요일
11:00-12:30 |
Concurrent Symposium IV - (Infect/Lab/Pathol)
Precision Transplant Diagnostics |
B1층 세미나실 2 | |
|---|---|---|---|
| 좌장 |
오은지 (가톨릭의대) 임범진 (연세의대) |
||
| 11:00-11:22 |
Microbiological Rapid Diagnostic Tests: Interpretation and Clinical Use
김태열 (성균관의대) |
||
| 11:22-11:45 |
AI Analysis of Genomic Information: Applications in Organ Transplantation
남민정 (성균관의대) |
||
| 11:45-12:07 |
Integrating Molecular Classifiers with Histopathology in Transplant Diagnostics
정민선 (연세의대 병리과) |
||
| 12:07-12:30 |
AI-Powered Digital Pathology for Transplant Rejection Detection
이성학 (가톨릭의대) |
||
|
03월 14일 토요일
12:30-13:30 |
Luncheon Symposium III 종근당
|
1층 컨퍼런스홀 | |
|---|---|---|---|
| 좌장 | 박재범 (성균관의대) | ||
| 12:30-13:30 |
Clinical Utility of 0.25 mg Tacrolimus Formulation in Managing Variability and Drug Interactions
방준배 (아주의대) |
||
|
03월 14일 토요일
12:30-13:30 |
Luncheon Symposium IV 다케다
|
B1층 세미나실 4 | |
|---|---|---|---|
| 좌장 | 김범석 (연세의대) | ||
| 12:30-13:30 |
CMV Treatment Strategies: Insight from the KOTRY/KOTRY-CMV Study
양재석 (연세의대) |
||
|
03월 14일 토요일
12:30-13:30 |
Luncheon Symposium V 녹십자
|
B1층 세미나실 1 | |
|---|---|---|---|
| 좌장 | 정동환 (울산의대) | ||
| 12:30-13:30 |
Role of antithrombin III in LT patients
정보현 (인제의대) |
||
|
03월 14일 토요일
13:30-14:00 |
대한이식학회 총회
|
1층 엑스포홀 | |
|---|---|---|---|
|
03월 14일 토요일
14:00-15:30 |
Concurrent Symposium VI - (Kidney/Pancreas II)
Optimizing Long-Term Outcomes in Kidney Transplant Recipients |
1층 엑스포홀 | |
|---|---|---|---|
| 좌장 |
최수진나 (전남의대) 정병하 (가톨릭의대) |
||
| 14:00-14:20 |
Immunological Surveillance for Long-Term Management of Transplant Recipients
이하정 (서울의대) |
||
| 14:20-14:40 |
Management of Post-Transplant Cardio Kidney Metabolic syndrome
황현석 (경희의대) |
||
| 14:40-15:00 |
Post-Transplant Malignancy: Screening, Prevention, and Management
이주한 (연세의대) |
||
| 15:00-15:20 |
Recurrent Primary Glomerulonephritis: Updated Clinical Approach
김창성 (전남의대) |
||
| 15:20-15:30 | Q&A | ||
|
03월 14일 토요일
14:00-15:30 |
Concurrent Symposium VII - (Liver II)
Portal–Systemic Shunt Dynamics: Systemic and Graft Impacts of Ligation |
1층 컨퍼런스홀 | |
|---|---|---|---|
| 좌장 |
유영경 (가톨릭의대) 서경석 (서울의대) |
||
| 14:00-14:20 |
Pathophysiology of Portal Steal and Clinical Impact in LT
정보현 (인제의대) |
||
| 14:20-14:40 |
Technical Pearls for Safe Splenorenal Shunt Ligation
주동진 (연세의대) |
||
| 14:40-15:00 |
Thrombosis after Ligation: Early Detection and Salvage
정동환 (울산의대) |
||
| 15:00-15:20 |
Endovascular Alternatives to Ligation: BRTO, PARTO, CARTO, and Embolization
최진우 (서울의대) |
||
| 15:20-15:30 | Discussion | ||
|
03월 14일 토요일
14:00-15:30 |
Concurrent Symposium IX - (Lung)
Age Matters in Lung Transplantation |
B1층 세미나실 4 | |
|---|---|---|---|
| 좌장 |
이진구 (연세의대) 박무석 (연세의대 호흡기내과) |
||
| 14:00-14:15 |
PRO/CON Debate: Should an Upper Age Limit Be Maintained in Lung Transplantation? – CON
전경만 (성균관의대 호흡기내과) |
||
| 14:15-14:30 |
PRO/CON Debate: Should an Upper Age Limit Be Maintained in Lung Transplantation? – PRO
조우현 (부산의대 호흡기내과) |
||
| 14:30-14:45 |
Panel discussion 1 and Q&A
박지명 (서울의대), 우아라 (연세의대), 박지은 (아주의대 호흡기내과), 함석진 (아주의대 흉부외과) |
||
| 14:45-15:00 |
Navigating Adolescence After Pediatric Lung Transplantation
김송이 (연세의대 호흡기내과) |
||
| 15:00-15:15 |
Size Matching in Pediatric Lung Transplantation
박샘이나 (서울의대) |
||
| 15:15-15:30 |
Panel discussion 2 and Q&A
김하은 (연세의대), 최선미 (서울의대 호흡기내과), 김도형 (부산의대 흉부외과), 이정희 (성균관의대) |
||
|
03월 14일 토요일
14:00-15:30 |
Concurrent Symposium VIII - (Heart II)
Key Trade-Offs in Heart Transplantation: Allocation, Organ Preservation, and Immunosuppression Strategies |
B1층 세미나실 1 | |
|---|---|---|---|
| 좌장 |
이해영 (서울의대) 윤영남 (연세의대) |
||
| 14:00-14:15 |
Status or Score? Updating Heart Allocation in Korea
조양현 (성균관의대) |
||
| 14:15-14:30 |
Conventional Storage or Advanced Perfusion? Donor Heart Preservation Under Real-World Constraints
김기태 (울산의대) |
||
| 14:30-14:45 |
Induction Therapy After Heart Transplant: Routine for All or Targeted Use?
김인철 (계명의대) |
||
| 14:45-15:00 |
Where Do mTOR Inhibitors Fit? First-Line Strategy or Selective Use in Heart Transplantation
이수용 (양산부산대병원) |
||
| 15:00-15:30 |
Discussion
주민호 (양산부산대병원), 현준호 (울산의대), 이희문 (부천세종병원), 이혜원 (부산의대), 손석호 (서울의대) |
||
|
03월 14일 토요일
14:00-15:30 |
Concurrent Symposium X (Xeno)
이종이식의 임상적용을 위한 현 상황에서의 점검 |
B1층 세미나실 2 | |
|---|---|---|---|
| 좌장 |
윤익진 (건국의대) 김현일 (옵티팜) |
||
| 14:00-14:20 |
Current Unsolved Questions in Clinical Xenotransplantation
이교원 (성균관의대) |
||
| 14:20-14:40 |
이종이식에서 Costimulatory blockade 의 역할과 전망
윤일희 (연세의대) |
||
| 14:40-15:00 |
췌도 이식의 임상적용을 위해 남은 과제들
김종민 (청주대 동물보건학과) |
||
| 15:00-15:20 |
이종이식의 임상적용을 위해 남은 법적, 사회적 과제들
권복규 (이화의대) |
||
| 15:20-15:30 | Q&A | ||
|
03월 14일 토요일
15:30-16:00 |
Closing Ceremony
|
All | |
|---|---|---|---|
This website is operated by the secretariat (hereafter referred to as ‘SECRETARIAT’ or ‘We’) of the ATW 2024 (hereafter referred to as ‘MEETING’), and this privacy policy applies to this website only.
At atweek.org (hereafter referred to as ‘WEBSITE’), the SECRETARIAT respects its participants and understands that you are concerned about privacy. We are posting this privacy policy to let you know what kind of information we collect, how it is handled, with whom it may be shared, what choices you have regarding the SECRETARIAT’s use of your information, and how you may access some of the data you provide to the SECRETARIAT.
As the SECRETARIAT continues to develop the WEBSITE and take advantage of technologies to improve the services we offer, the privacy policy may change. We therefore encourage you to refer to this policy on an ongoing basis so that you understand the SECRETARIAT’s current privacy policy.
If you have any questions about this policy, please contact our Privacy Protection Manager at atweek@insession.co.kr
What Information Do We Collect? The SECRETARIAT collects various types of information depending upon how you use the WEBSITE:
A cookie is a small piece of information sent by a website, which is saved on your hard disk by your computer's browser. It holds information a site may need to interact with you and personalize your experience. At the WEBSITE, we use two kinds of cookies: session cookies and persistent cookies. Session cookies exist only for as long as your browser remains open. Once you exit your browser, they go away. The SECRETARIAT uses session cookies to maintain information we need to have in order for you to register for the MEETING. For example, the Session ID cookie that we ask your browser to hold retains the ID for My Page. Without the Session ID cookie, you cannot add and modify any information that you input at the time of your sign-up.
Persistent cookies, in contrast, last from visit to visit; they do not go away when you exit your browser. At the WEBSITE, we use persistent cookies to give you a more personalized browse and to help you navigate the WEBSITE more efficiently. The SECRETARIAT will use your information to enhance your site experience. However, you can use the WEBSITE without accepting a persistent cookie. To do so, you should set your browser options to reject persistent cookies. Alternatively, you can set your browser to notify you when you receive a cookie, which gives you the opportunity to decide whether you want to accept it or not. In many instances, the Help button on your browser toolbar will tell you how you can take these steps.
Cookies can be used by a website to recognize you. But that does not necessarily mean any personal information is stored in the cookies. At the WEBSITE, we store no personal information about you in the cookies. Anything you choose to tell us about yourself (such as your address and email address) is stored safely and separately on our secured servers, and you need to provide a password to access it.
The SECRETARIAT also uses cookies to look at how groups, rather than individuals, use the WEBSITE. In our administration page, we can observe which aisles and departments are most heavily trafficked and determine the best method to improve the experience for visitors. On the web, cookies help us develop a similar understanding so that we can continue to improve the arrangement, product offerings, registration and abstract submission at the WEBSITE.
The SECRETARIAT may use your information in a number of ways, including the following:
The information gathered may be shared with the ATW 2024 Organizing Committee and our family associations. We also share the information with third parties, including responsible committees with which we have a relationship. For example:
In most of the above situations, these third parties will receive your information because you will be visiting their websites or using their links and, in doing so, you may provide information directly to them. You therefore should refer to their privacy policies to understand how they handle your information and what kinds of choices you have.
The SECRETARIAT also may share your personal information with outside companies that perform services for the MEETING. For example, we may retain an outside company to manage a database containing certain participants’ information or to create and distribute an email offering. In those situations, the outside party is performing work for the WEBSITE, and the SECRETARIAT includes language in its contracts stating that your information is to be used only to provide the services requested by the SECRETARIAT.
Additionally, the SECRETARIAT may share account or other information when we believe it is necessary to comply with law or to protect the SECRETARIAT’s interests or property. This may include sharing information with other companies, committees, lawyers, credit bureaus, agents or government agencies in connection with issues related to fraud, credit or debt collection.
In the event that some or all of the business assets of the MEETING are sold or transferred, we generally would transfer the corresponding information about the participants of the MEETING.
Finally, the SECRETARIAT may share your personal information with unrelated outside companies so that they can directly promote the services to you if we feel that the companies offer services that we believe may be of interest. We also may provide you with the opportunity to create an account on our website to receive email offers from other companies.
What Choices Do You Have Regarding the Use of Your Information? The SECRETARIAT provides you with a number of choices regarding our handling of your personal information.
If you wish to change your email preferences, please click on the unsubscribe link at the bottom of any SECRETARIAT’s e-mail and describe the request such as “Please do not send me email," or “Keep my email address private."
Note: Once you have submitted your email opt-out request, you should assume that it has been successfully received and your request is being processed. Please allow us 10 business days from when the request is received to complete the removal, as some of our promotions may already have been in process before you submitted your request.
You also may use the address and phone number above to request that we not reveal your personal information to unrelated third parties for marketing purposes. If you choose to write to the SECRETARIAT, please include your name, address, and credit card account number to be used for settlement and state "NO THIRD PARTY SHARING" in your request.
If you are a user who has already signed up for the MEETING, you can update your information in “My Page,” and if you have questions about your status, you may also check them online in “My Page.”
If you would like, you may also an email to the SECRETARIAT.
Questions regarding your charge account may be forwarded to our Credit Customer Service Department.
The SECRETARIAT has put in place various physical, electronic, and managerial procedures to try to safeguard and secure the information we collect online. For example, private account and customer information is located on a secured server behind a firewall; it is not directly connected to the Internet. Encryption is a process by which a message or information is scrambled while it is in transit to the SECRETARIAT. It is based on a key that has two different parts, public and private. The public part of the key is distributed to those with whom you want to communicate. The private part is for the recipient's use only. So long as you use a browser that allows for encryption, when you send personal information to the SECRETARIAT, you use a public key to encrypt your personal information. If your information is intercepted during the transmission, it is scrambled and very difficult to decrypt. Once we receive your encrypted personal information, we use the private part of our key to decode it.
Please note however that while we implement many security measures on this site, 100% security cannot be guaranteed.
Thank you for your visit to the WEBSITE. If you have any questions or comments about this policy, please email the SECRETARIAT (atweek@insession.co.kr).
ATW 2024 will be held in Seoul, from November 14 to November 16, 2024. Your use of atweek.org will always be subject to, at a minimum, the terms and conditions set out in this document. These are referred to as the "Master Terms." In addition, your use of the Website may also be subject to the terms of any legal notice applicable to the Website in addition to the Master Terms. All such terms supplementing these Master Terms are referred to below as "Additional Terms." The Master Terms, together with any Additional Terms, form a binding legal agreement between you and ATW 2024 in relation to your use of the Website. Collectively, this legal agreement is referred to below as the "Terms." If there is any contradiction between the Additional Terms and the Master Terms, then the Additional Terms shall take precedence in relation to the Website to which the Additional Terms apply.
Your access or use of atweek.org in any way signifies that you have read, understand, and agree to be bound by the terms. By accessing or using atweek.org, you also represent that you have the legal authority to accept the Terms on behalf of yourself and any party you represent in connection with your use of the Website. If you do not agree to the Terms, you are not authorized to use the Website.
ATW 2024 may change, remove, add to modify the Terms, and reserves the right to do so in its discretion. In that case, we will post the updated Master Terms or Additional Terms, as relevant, to the Website and indicate the date of revision. We may send a message to your email address, or we may display a notice on the Website indicating that the Terms have changed. All amended Terms take effect immediately. If you do not agree with any modification to the Terms, you may terminate this agreement by ceasing use of the Website. Your continued use of the Website after the revised Terms are effective indicates that you have read, understood, and agreed to those Terms.
ATW 2024 makes the Website available to you on the Terms. You may only use the Website in accordance with these Master Terms and any applicable Additional Terms. In particular but without limitation, you may not use the Website for any purpose that is unlawful or prohibited by these Master Terms, any applicable Additional Terms, or any other conditions or notices that are made available on any Website.
The Website Services are controlled and offered by ATW 2024 in Korea. ATW 2024 makes no representations that the Website is appropriate or available for use in other locations. If you are accessing or using any Website from other jurisdictions, you do so at your own risk and you are responsible for compliance with local laws.
You understand that all material, data, and information, (collectively, "Content") which you may have access to through your use of the Website are the sole responsibility of the person from which such Content originated. This includes assertions that persons may make, expressly or impliedly, about the provenance and ownership of Content that they supply, upload, list and/or link to. You acknowledge that ATW 2024 does not make any representations or warranties about the accuracy, integrity or quality of the Content made available at the instigation of users of the Website. You understand that by using the Website, you may be exposed to Content that is offensive, indecent or objectionable. Under no circumstances is ATW 2024 liable in any way for any Content, including but not limited to: any infringing Content, any errors or omissions in Content, or for any loss or damage of any kind incurred as a result of the use of any Content posted, transmitted to, linked to or otherwise accessible or made available via the Website Services.
Content You Provide.You may only submit Content to the Website. This means that you can only submit Content that you yourself create, that is in the public domain or that you have been expressly granted the right to submit consistent with the Terms. For the avoidance of doubt, Content that infringes the rights of any third party must not be submitted. You represent, warrant, and agree that no Content of any kind submitted, posted or otherwise shared by you on or through any of the Website Services, violates or infringes upon the rights of any third party, including copyright, trademark, privacy, publicity or other personal or proprietary rights, or contains libelous, defamatory or otherwise unlawful material. Further, you represent, warrant, and agree not to submit any personally identifiable information. ATW 2024 may review your submissions and may delete or remove without notice any Content in its sole discretion that ATW 2024 determines violates the Terms or that may be offensive, illegal, or that might violate the rights, harm or threaten the safety of others. ATW 2024 does not endorse or support any Content posted by you. You alone are responsible for creating backup copies and replacing any Content you post on the Website, and you authorize ATW 2024 to make copies of your Content as we deem necessary in order to facilitate the posting of your Content on the Website.
Use of Content on the Website.You represent and warrant to ATW 2024 that you will use any and all Content on our Website in accordance with the applicable license. By using the Website, you agree that you are solely responsible for your use of any and all Content made available thereon. You agree that you must evaluate, and bear all risks associated with, the use of any Content, including any reliance on the provenance, ownership, accuracy, completeness or reliability of such Content. In this regard, you acknowledge that you may not rely on any Content made available on the Website without your own independent evaluation of that Content. ATW 2024 does not guarantee that Content made available on the Website does not infringe the rights of any third party.
By registering for an account on the Website, you agree to abide by all of the terms and conditions of these Master Terms and any applicable Additional Terms. ATW 2024 reserves the right to modify or discontinue the accounts of Registered Users and related Services at any time. ATW 2024 disclaims any and all liability to Registered Users.
SecurityYou agree to (a) provide accurate, current and complete information about you, if and as may be prompted by the registration process on the Website, (b) maintain the security of your password and identification, (c) maintain and promptly update your registration information and any other information you provide, and to keep it accurate and complete to, among other things, allow us to contact you, and (d) be fully responsible for all use of your account and for any actions that take place using your account. You may not set up an account or membership on behalf of another individual or entity.
Termination and Inactivation of User Accounts.Your participation as a Registered User terminates automatically upon your breach of any of these Master Terms or applicable Additional Terms. In addition, ATW 2024 may, at any time: (a) modify, suspend or terminate the operation of or access to your user account for any reason; (b) modify or change the Website and Services and any applicable Terms and policies governing your user account and related Website Services for any reason; and (c) interrupt user accounts and related Website Services for any reason, all as ATW 2024 deems appropriate in its discretion. Your access to your account and use of the Website may be terminated by you or by ATW 2024 at any time and for any reason whatsoever without notice. In addition, ATW 2024 reserves the right to delete and purge any account and all Content associated therewith following any prolonged period of inactivity, all as may be determined by ATW 2024 in its complete discretion.
To the fullest extent permitted by the applicable law, ATW 2024 offers the Website and Services as-is and makes no representations or warranties of any kind concerning the Website Services. ATW 2024 does not warrant that the functions or content contained on the Website will be uninterrupted or error-free, that defects will be corrected, or that ATW 2024's servers are free of viruses or other harmful components. ATW 2024 does not warrant or make any representation regarding the use or the result of use of the Content in terms of accuracy, reliability, or otherwise.
ATW 2024 shall not be responsible or liable whatsoever in any manner for any Content posted on the Website for your use of the Website Services.
ATW 2024 is committed to handling responsibly the information and data we collect through our Website and agrees to use your personal information in accordance with the Privacy Policy. The Privacy Policy is hereby incorporated by reference into these Master Terms.
ATW 2024 respects the intellectual property rights of others, and we prohibit users of our Website from submitting, uploading, posting or otherwise transmitting any materials that violate another person's intellectual property rights.
These Master Terms and any Additional Terms will continue to apply until terminated by either you or ATW 2024 as set out below. Your right to access and use the Website terminates automatically upon your breach of any of these Master Terms or Additional Terms that may apply to any of the Website Services. ATW 2024 may, at any time: (a) modify, suspend or terminate the operation of or access to any of the Website Services, or any portion of the Website Services, for any reason; (b) modify or change the Website Services, or any portion of the Website Services, and any Master Terms, Additional Terms, and other policies governing the use of the Website Services, for any reason; (c) interrupt the operation of the Website Services, or any portion of the Website Services, for any reason, all as ATW 2024 deems appropriate in its sole discretion. Your access to, and use of, the Website Services may be terminated by you or by ATW 2024 at any time and for any reason. ATW 2024 will use reasonable efforts to notify you in advance about any material modification, suspension or termination by ATW 2024 that is not caused by your breach of the Terms.
This Master Term constitutes the entire agreement between you and ATW 2024 relating to this subject matter and supersedes all prior, contemporaneous, and future communications between you and ATW 2024.
These Terms of Use are Effective as of June 4, 2024